Kallenberg, Judith
Milea, Dominique
Breuer, Thomas https://orcid.org/0000-0003-2532-0505
Philippot, Agathe https://orcid.org/0009-0004-6938-2665
Funding for this research was provided by:
GSK
Article History
Received: 16 December 2025
Accepted: 9 February 2026
First Online: 25 February 2026
Change Date: 18 March 2026
Change Type: Update
Change Details: The original online version of this article was revised: The copyright holder for this article was incorrectly given as ‘The Author(s)’ but should have been ‘GSK Plc.’.
Change Date: 22 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-026-01338-z
Declarations
:
: Judith Kallenberg, Dominique Milea, Thomas Breuer, and Agathe Philippot are GSK employees and hold financial equities in GSK. Judith Kallenberg, Dominique Milea, Thomas Breuer, and Agathe Philippot declare no other financial and non-financial relationships and activities.
: This article is based on previously conducted studies and published data, and does not contain any new studies with human participants or animals performed by any of the authors.
: AS01 is a trademark owned by or licensed to the GSK group of companies.